PT
Healthcare & Life Sciences

Pano Therapeutics

Pano Therapeutics is a Healthcare & Life Sciences startup based in the United States, 1 tracked investor.

Active
2019
Founded
1
Investors

About Pano Therapeutics

Based in the United States, Pano Therapeutics is a startup founded in 2019. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Pano Therapeutics is developing PAN1195, an oral, once-daily CNS-optimized biguanide aimed at treating Fragile X Syndrome and related syndromic neurodevelopmental disorders through targeted pharmacology.

Explore Pano Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States